Detalhe da pesquisa
1.
Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda.
BMC Infect Dis
; 24(1): 70, 2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38200467
2.
Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda.
Res Sq
; 2023 Sep 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37841871
3.
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda.
Open Forum Infect Dis
; 8(6): ofab173, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34189166
4.
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda.
J Clin Tuberc Other Mycobact Dis
; 25: 100286, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34816021
5.
High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
PLoS One
; 15(5): e0232543, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32413052